KHTRF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Knight Therapeutics Inc

Watchlist Manager

Watchlist

Price: 7.15 USD Market Closed

Market Cap: $724.8m

K	Knight Therapeutics Inc OTC:KHTRF	CA
	Komax Holding AG SIX:KOMN	CH
S	SCB X PCL SET:SCB	TH
D	Digicontent Ltd NSE:DGCONTENT	IN
D	DoorDash Inc F:DD2	US
C	China Literature Ltd F:C2X	CN
	Elemental Royalty Corp NASDAQ:ELE	CA
	Universal Stainless & Alloy Products Inc NASDAQ:USAP	US
A	ASML Holding NV MIL:ASML	NL
N	Nextera Energy Inc SWB:FP3	US
	Empress Royalty Corp XTSX:EMPR	CA
A	Agricola Nacional SAC e I SGO:ANASAC	CL
F	F I P P SA XBER:FIPP	FR

Profitability Summary

Knight Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Sustainable 3Y Average Gross Margin

47%

Gross Margin is Increasing

45% > 49%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

-4% > 6%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-5% > 3%

Exceptional Free Cash Flow Margin

19%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

1% > 19%

Low ROE

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.